Search
BridgeBio Pharma Inc
BBIOAdd to Watchlist
66.610USD
-0.700-1.04%
Close 09-18 16:00（ET）
13.01BMarket Cap
LossP/E TTM
BBIO Financials
See BridgeBio Pharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
13.01B
Dividend TTM
0.00
P/E TTM
-17.78
EPS TTM
-3.75
Revenue
502.08M
Net Profit
-535.76M
ROE
0.00%
ROA
-64.80%
BridgeBio Pharma Inc Earnings Date
Latest Release
Aug 10, 2026
EPS / Forecast
-0.78/-0.58
Revenue / Forecast
243.68M/218.74M
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What is the total revenue of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total revenue reached 502.08M, with a year-on-year change of 221.90M.
What are the current assets of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its current assets were 797.75M, with a year-on-year change of 10.69.
What are the total assets of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total assets of BridgeBio Pharma Inc were 936.02M, with a year-on-year change of 1.82.
What are the total liabilities of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total liabilities of BridgeBio Pharma Inc were 3.01B, with a year-on-year change of 26.74.
What is the total equity of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total equity of BridgeBio Pharma Inc was -2.08B, with a year-on-year change of -42.46.
What is the net operating income of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net operating income of BridgeBio Pharma Inc was -502.06M, with a year-on-year change of 13.04.
What is the net investment of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net investment of BridgeBio Pharma Inc was -24.49M, with a year-on-year change of -140.29.
What is the net financing of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net financing of BridgeBio Pharma Inc was 359.29M, with a year-on-year change of -52.00.
What is the Earnings Per Share (EPS) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.79, with a year-on-year change of -31.46.
What is the net income of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net income was -724.93M, with a year-on-year change of -35.31.
What is the net margin of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net profit margin was -145.98, with a year-on-year change of 40.38.
What is the gross margin of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its gross margin was 95.82, with a year-on-year change of -2.47.
What is the debt-to-asset ratio of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its debt-to-asset ratio was 289.26, with a year-on-year change of 20.85.
What is the Return on Assets (ROA) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -79.01, with a year-on-year change of -6.56.
What is the operating profit of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its operating profit was -502.06M, with a year-on-year change of 13.04.